Quantbot Technologies LP Acquires 6,694 Shares of Cryoport, Inc. (NASDAQ:CYRX)

Quantbot Technologies LP grew its stake in Cryoport, Inc. (NASDAQ:CYRXFree Report) by 109.0% during the third quarter, HoldingsChannel.com reports. The firm owned 12,838 shares of the company’s stock after buying an additional 6,694 shares during the period. Quantbot Technologies LP’s holdings in Cryoport were worth $176,000 at the end of the most recent quarter.

A number of other large investors also recently made changes to their positions in the stock. Credit Suisse AG lifted its stake in shares of Cryoport by 1.1% in the 3rd quarter. Credit Suisse AG now owns 49,215 shares of the company’s stock valued at $1,199,000 after purchasing an additional 524 shares during the period. American International Group Inc. raised its stake in Cryoport by 3.5% during the 2nd quarter. American International Group Inc. now owns 20,846 shares of the company’s stock worth $646,000 after buying an additional 708 shares during the period. FMR LLC raised its stake in Cryoport by 34.1% during the 1st quarter. FMR LLC now owns 2,935 shares of the company’s stock worth $70,000 after buying an additional 747 shares during the period. State of Wyoming raised its stake in Cryoport by 42.7% during the 4th quarter. State of Wyoming now owns 3,026 shares of the company’s stock worth $53,000 after buying an additional 905 shares during the period. Finally, Bullseye Asset Management LLC raised its stake in Cryoport by 0.8% during the 2nd quarter. Bullseye Asset Management LLC now owns 127,016 shares of the company’s stock worth $2,191,000 after buying an additional 1,000 shares during the period. Institutional investors and hedge funds own 92.90% of the company’s stock.

Cryoport Stock Performance

Shares of Cryoport stock opened at $15.89 on Monday. The firm has a market cap of $778.04 million, a price-to-earnings ratio of -14.06 and a beta of 1.58. The stock’s 50-day moving average is $15.32 and its 200-day moving average is $13.85. The company has a debt-to-equity ratio of 0.74, a current ratio of 12.23 and a quick ratio of 11.58. Cryoport, Inc. has a one year low of $9.00 and a one year high of $24.42.

Analysts Set New Price Targets

Separately, Needham & Company LLC raised their price objective on Cryoport from $18.00 to $19.00 and gave the stock a “buy” rating in a research note on Thursday, January 18th. Five analysts have rated the stock with a hold rating and one has assigned a buy rating to the company. Based on data from MarketBeat.com, Cryoport currently has an average rating of “Hold” and a consensus price target of $18.14.

Read Our Latest Stock Report on CYRX

Cryoport Company Profile

(Free Report)

Cryoport, Inc provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and human reproductive medicine markets in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments: Global Logistics Solutions and Global Bioservices. The company offers Cryoport Express Shippers; Cryoport ELITE -80°C Gene Therapy Shipper; Cryoport ELITE Cryosphere Shipper; Cryoport consulting services, including physical, thermal, and shipping qualifications of shipping systems and/or packaging to developing custom packaging solutions; and Cryoport bioservices, such as controlled temperature storage, fulfilment, kit production, secondary packaging, labelling of therapeutic products, and GMP raw materials storage services.

Featured Articles

Want to see what other hedge funds are holding CYRX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cryoport, Inc. (NASDAQ:CYRXFree Report).

Institutional Ownership by Quarter for Cryoport (NASDAQ:CYRX)

Receive News & Ratings for Cryoport Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cryoport and related companies with MarketBeat.com's FREE daily email newsletter.